On comparing the number of EVs released from these different human cancer cell lines, we observed that PEG-SMRwt-Clu peptide, SMRwt-CPP peptide, MKT-077, omeprazole and DMA mortalin inhibitors all reduced the number of EVs released, and this was maintained during the five days of treatment. This evidence concerns the gene HSPA9 and cancer.